A Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Phase 2b Clinical Study to Evaluate the Efficacy and Safety of HK-660S in Patients With Primary Sclerosing Cholangitis (PSC)
Latest Information Update: 22 May 2025
At a glance
- Drugs Beta lapachone (Primary)
- Indications Primary sclerosing cholangitis
- Focus Therapeutic Use
- Sponsors CUROME BIOSCIENCES
Most Recent Events
- 22 May 2025 New trial record